North America held the largest share of the sepsis diagnostics market in 2025, accounting for 49.80% of revenue, due to strong healthcare facilities and early use of diagnostic technologies. Asia Pacific is expected to grow at a CAGR of 8.2% during 2... Explore Report »
Research Reports in Clinical Diagnostics
Showing 10 results in Clinical Diagnostics
The cancer biomarkers market size was valued at USD 26.48 billion in 2025. The market is projected to account for a CAGR of 11.2% between 2026 and 2034. The market is driven by the global cancer epidemic, advancements in cancer biomarker discovery, i... Explore Report »
Global atopic dermatitis clinical trials market size was valued at USD 2.87 billion in 2025. The market is anticipated to grow from USD 3.18 billion in 2026 to USD 7.46 billion by 2034, exhibiting a CAGR of 11.20% during the forecast period. 2025 Mar... Explore Report »
The Real-time PCR, Digital PCR, And End-point PCR Market size was valued at USD 8.23 billion in 2025 and is anticipated to exhibit the CAGR of 4.3% during the forecast period. The growth is driven by rise in cases of infectious diseases, advancement ... Explore Report »
The global in vitro diagnostics market size was valued at USD 80.02 billion in 2024 and is projected to register a CAGR of 6.7% from 2025 to 2034. Rising focus on developing tests that offer greater sensitivity, specificity, and speed drives the indu... Explore Report »
The Europe point of care (PoC) diagnostics market size was valued at USD 9.28 billion in 2024, growing at a CAGR of 3.92% from 2025-2034. Key factors driving demand include rising shift towards self-testing, supportive government policies and healthc... Explore Report »
The global point of care (PoC) diagnostics market size was valued at USD 55.98 billion in 2024, growing at a CAGR of 9.40% from 2025-2034. Key factors driving demand include rising demand for rapid and accurate testing solutions, government and insti... Explore Report »
The U.S. point of care (PoC) diagnostics market size was valued at USD 9.69 billion in 2024, growing at a CAGR of 6.88% from 2025-2034. Key factors driving demand include shift towards value based care and decentralized testing, supportive government... Explore Report »
The U.S. C-reactive protein testing market size was valued at USD 769.66 million in 2024, growing at a CAGR of 5.02% from 2025 to 2034. Key factors driving demand for C-reactive protein testing include growing demand for precision medicine, rising he... Explore Report »
The global C-reactive protein (CRP) testing market was valued at USD 2.9 billion in 2024 and is projected to grow at a CAGR of 8.80% from 2025 to 2034. Market expansion is fueled by increasing incidence of inflammatory diseases and chronic conditions... Explore Report »
